PRASAD SUYASH

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2022-07-07	2022-07-06	Taysha Gene Therapies Inc (TSHA)	PlS Planned sale	84,923 -0.1% 462.23 US$2,017,690	84,923 -0.1%	462.23	US$2,017,690
2022-07-07	2022-07-05	Taysha Gene Therapies Inc (TSHA)	PlS Planned sale	10,659 +37.4% 414.67 US$313,446	10,659 +37.4%	414.67	US$313,446
2022-07-01	2022-07-01	Taysha Gene Therapies Inc (TSHA)	PlS Planned sale	70,313 +14.3% 144.03 US$4,406,700	70,313 +14.3%	144.03	US$4,406,700
2022-07-01	2022-06-30	Taysha Gene Therapies Inc (TSHA)	PlS Planned sale	13,892 -2.4% 3.72 US$51,678	13,892 -2.4%	3.72	US$51,678
2022-07-01	2022-06-29	Taysha Gene Therapies Inc (TSHA)	PlS Planned sale	12,324 -2.1% 3.81 US$46,954	12,324 -2.1%	3.81	US$46,954
2019-05-15	2019-05-13	Audentes Therapeutics Inc (BOLD)	PlS Planned sale	54 -0.3% 37.72 US$2,037	54 -0.3%	37.72	US$2,037
2019-05-15	2019-05-13	Audentes Therapeutics Inc (BOLD)	PlS Planned sale	9,946 -35.2% 36.98 US$367,761	9,946 -35.2%	36.98	US$367,761
2019-02-27	2019-02-25	Audentes Therapeutics Inc (BOLD)	PlS Planned sale	10,000 -35.4% 30.06 US$300,553	10,000 -35.4%	30.06	US$300,553